LEADER 00000cam  2200697 i 4500 
001    ocn819641635 
003    OCoLC 
005    20161202012128.0 
008    121123s2013    mauab    b    001 0 eng   
010      2012047199 
015    GBB311188|2bnb 
016 7  101596382|2DNLM 
016 7  016270016|2Uk 
019    827267181|a842360838 
020    087893510X 
020    9780878935109 
035    (OCoLC)819641635|z(OCoLC)827267181|z(OCoLC)842360838 
040    DNLM/DLC|beng|erda|cDLC|dYDX|dNLM|dOCLCO|dYDXCP|dUKMGB
       |dCDX|dNLGGC|dMMU|dWEX|dERD|dOCLCF|dIXA|dOCL|dOCLCQ|dS3O
       |dU9X|dSTJ 
042    pcc 
049    STJP 
050 00 RM315|b.M478 2013 
060 00 2013 F-188 
060 10 QV 77.2 
082 00 615.7/88|223 
096    QV 77.2|bM612P 2013 
100 1  Meyer, Jerrold S.,|d1947-|eauthor. 
245 10 Psychopharmacology :|bdrugs, the brain, and behavior /
       |cJerrold S. Meyer, University of Massachusetts, Linda F. 
       Quenzer, University of Hartford. 
250    Second edition. 
264  1 Sunderland, Massachusetts :|bSinauer Associates, Inc.,
       |c[2013] 
300    xxii, 722 pages :|billustrations (chiefly color), color 
       maps ;|c29 cm 
336    text|btxt|2rdacontent 
337    unmediated|bn|2rdamedia 
338    volume|bnc|2rdacarrier 
500    "Chapter 17, Environmental Neurotoxicants and Endocrine 
       Disruptors by Susan A. Rice, Susan A. Rice and Associates,
       Inc. ; Chapter 21, Neurodegenerative Diseases by Jennifer 
       R. Yates, Ohio Wesleyan University"-- Title page. 
504    Includes bibliographical references and index. 
505 0  Principles of pharmacology -- Structure and function of 
       the nervous system -- Chemical signaling by 
       neurotransmitters and hormones -- Methods of research in 
       psychopharmacology -- Catecholamines -- Serotonin -- 
       Acetylcholine -- Glutamate and GABA -- Drug abuse and 
       addiction -- Alcohol -- The opiates -- Psychomotor 
       stimulants : cocaine and the amphetamines -- Nicotine and 
       caffeine -- Marijuana and the cannabinoids -- 
       Hallucinogens, PCP, and ketamine -- Inhalants, GHB, and 
       anabolic-androgenic steroids -- Environmental 
       neurotoxicants and endocrine disruptors -- Anxiety 
       disorders : sedative-hypnotic-anxiolytic drugs -- 
       Affective disorders : antidepressants and mood stabilizers
       -- Schizophrenia : antipsychotic drugs -- 
       Neurodegenerative disorders. 
520 8  Encompassing recent advances in molecular pharmacology and
       brain imaging, this text covers historical accounts of 
       drug use, through clinical and preclinical behavioural 
       studies, to the latest research on drug effects in 
       transgenic mouse models. 
650  0 Psychopharmacology. 
650  0 Brain chemistry. 
650  4 Molecular pharmacology. 
650  7 Brain chemistry.|2fast|0(OCoLC)fst00837713 
650  7 Psychopharmacology.|2fast|0(OCoLC)fst01081659 
650  7 Psykofarmakologi.|2swemesh 
650  7 Läkemedelsterapi.|2sao 
650 12 Psychotropic Drugs|xpharmacokinetics 
650 12 Psychotropic Drugs|xtherapeutic use 
650 17 Psychofarmacologie.|2gtt 
650 22 Nervous System|xdrug effects 
650 22 Brain Chemistry|xdrug effects 
650 22 Mental Disorders|xdrug therapy 
650 22 Psychopharmacology|xmethods 
655  7 Leermiddelen (vorm)|2gtt 
700 1  Quenzer, Linda F.,|eauthor. 
700 1  Rice, Susan A.,|ewriter of added text. 
700 1  Yates, Jennifer R.,|ewriter of added text. 
994    C0|bSTJ